Operations and Pelvic Muscle Training in the Management of Apical Support Loss: The OPTIMAL Trial
OPTIMAL
9 other identifiers
interventional
374
1 country
9
Brief Summary
Pelvic organ prolapse is common among women with a prevalence that has been estimated to be as high as 30%. Pelvic organ prolapse often involves a combination of support defects involving the anterior, posterior and/or apical vaginal segments. While the anterior vaginal wall is the segment most likely to demonstrate recurrent prolapse after reconstructive surgery, reoperations are highest among those who require apical suspension procedures with or without repair of other vaginal segments (12%-33%). Despite the substantial health impact, there is a paucity of high quality evidence to support different practices in the management of prolapse, particularly surgery. Thus, the objectives of the Operations and Pelvic Muscle Training in the Management of Apical Support Loss (OPTIMAL) Trial are:
- 1.to compare sacrospinous ligament fixation (SSLF) to uterosacral vaginal vault ligament suspension (ULS); and
- 2.to assess the role of perioperative behavioral therapy/pelvic muscle training (PMT) in women undergoing vaginal surgery for apical or uterine prolapse and stress urinary incontinence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2008
Longer than P75 for not_applicable
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 9, 2008
CompletedFirst Posted
Study publicly available on registry
January 18, 2008
CompletedStudy Start
First participant enrolled
February 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2013
CompletedResults Posted
Study results publicly available
October 22, 2020
CompletedOctober 22, 2020
October 1, 2020
5.4 years
January 9, 2008
September 1, 2020
October 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Surgical Success
The absence of the following: (1) descent of the vaginal apex more than one-third into the vaginal canal; (2) anterior or posterior vaginal wall descent beyond the hymen; (3) bothersome vaginal bulge symptoms as indicated by an affirmative response to either 'Do you usually have a sensation of bulging or protrusion from the vaginal area?' or 'Do you usually have a bulge or something falling out that you can see or feel in the vaginal area?' in the Pelvic Floor Distress Inventory and any response other than 'not at all' to the question 'How much does this bother you?'; or (4) re-treatment for prolapse by either surgery or pessary.
24 months
Anatomic Failure
Anatomic failure is defined by one of the following: descent of the vaginal apex more than one-third into the vaginal canal, anterior or posterior vaginal wall descent beyond the hymen, or re-treatment for prolapse.
24 months
Urinary Distress Inventory at 6 Months
The Pelvic Floor Distress Inventory is a validated, self-reported instrument used to evaluate pelvic floor symptoms. It consists of 3 scales: 1. Pelvic Organ Prolapse Distress Inventory (POPDI, with 3 subscales), 2. Colorectal Anal Distress Inventory (CRADI, with 4 subscales), and 3. Urinary Distress Inventory (UDI, with 3 subscales). Scores are calculated by multiplying the mean value of all questions answered by 25 for the subscales and then adding the subscales. The range of responses for the UDI is: 0-300 with 0 (least distress) to 300 (most distress). Lower scores indicate better function / fewer symptoms.
6 months
Secondary Outcomes (9)
Change From Baseline: Urinary Distress Inventory
Baseline and 24 months
Change From Baseline: Pelvic Organ Prolapse Distress Inventory
Baseline and 24 months
Change From Baseline: Colorectal Anal Distress Inventory
Baseline and 24 months
Urinary Impact Questionnaire Change From Baseline to 24 Months
Baseline and 24 months
Pelvic Organ Prolapse Impact Questionnaire Change From Baseline to 24 Months
Baseline and 24 months
- +4 more secondary outcomes
Study Arms (4)
SSLF and PMT
EXPERIMENTALSacrospinous Ligament Fixation (SSLF) and Pelvic Muscle Training \& Exercises (PMT)
ULS and PMT
EXPERIMENTALUterosacral Vaginal Vault Ligament Suspension (ULS) and Pelvic Muscle Training \& Exercises (PMT)
SSLF without PMT
EXPERIMENTALSacrospinous Ligament Fixation (SSLF) without Pelvic Muscle Training \& Exercises (PMT)
ULS without PMT
EXPERIMENTALUterosacral Vaginal Vault Ligament Suspension (ULS) without Pelvic Muscle Training \& Exercises (PMT)
Interventions
Eligibility Criteria
You may qualify if:
- Stage 2 to 4 prolapse
- Prolapse of the vaginal apex or cervix to at least half way into the vaginal canal (POPQ Point C \> -TVL/2) \[TVL stands for total vaginal length\]
- Vaginal bulge symptoms as indicated by an affirmative response to either questions on the Pelvic Floor Distress Inventory (PFDI)
- Vaginal surgery for prolapse is planned, including a vaginal apical suspension procedure.
- Stress incontinence symptoms as indicated by an affirmative response to the PFDI Stress incontinence subscale
- Documentation of transurethral stress leakage on an office stress test or urodynamics with or without prolapse reduction within the previous 12 months
- A tension free vaginal tape (TVT) is planned to treat stress urinary incontinence.
- A pelvic muscle training (PMT) visit can be performed at least 2 weeks and not more than 4 weeks before surgery.
- Available for 24-months of follow-up.
- Able to complete study assessments, per clinician judgment
- Able and willing to provide written informed consent
You may not qualify if:
- Contraindication to sacrospinous ligament fixation (SSLF), uterosacral vaginal vault ligament suspension (ULS), or TVT in the opinion of the treating surgeon.
- History of previous surgery that included a SSLF or ULS. (Previous vaginal vault suspensions using other techniques or in which the previous technique is unknown are eligible.)
- Pelvic pain or dyspareunia due to levator ani spasm that would preclude a PMT program.
- History of previous synthetic sling procedure for stress incontinence.
- Previous adverse reaction to synthetic mesh.
- Urethral diverticulum, current or previous (i.e., repaired)
- History of femoral to femoral bypass.
- Current cytotoxic chemotherapy or current or history of pelvic radiation therapy.
- History of two inpatient hospitalizations for medical comorbidities in the previous 12 months.
- Subject wishes to retain her uterus. \[Both ULS and SLS include removal of the uterus, if not previously removed\]
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (9)
The University of Alabama at Birmingham
Birmingham, Alabama, 35233-7333, United States
Kaiser Permanente Bellflower
Bellflower, California, 90706, United States
University of California, San Diego Medical Center
La Jolla, California, 92037, United States
Kaiser Permanente
San Diego, California, 92120, United States
Loyola University Medical Center
Maywood, Illinois, 60153, United States
Duke University
Durham, North Carolina, 27710, United States
Cleveland Clinic
Cleveland, Ohio, 44195, United States
University of Texas Southwestern
Dallas, Texas, 75390, United States
University of Utah
Salt Lake City, Utah, 84132, United States
Related Publications (9)
Barber MD, Brubaker L, Menefee S, Norton P, Borello-France D, Varner E, Schaffer J, Weidner A, Xu X, Spino C, Weber A; Pelvic Floor Disorders Network. Operations and pelvic muscle training in the management of apical support loss (OPTIMAL) trial: design and methods. Contemp Clin Trials. 2009 Mar;30(2):178-89. doi: 10.1016/j.cct.2008.12.001. Epub 2008 Dec 16.
PMID: 19130903BACKGROUNDBorello-France D, Newman DK, Markland AD, Propst K, Jelovsek JE, Cichowski S, Gantz MG, Balgobin S, Jakus-Waldman S, Korbly N, Mazloomdoost D, Burgio KL; NICHD Pelvic Floor Disorders Network. Adherence to Perioperative Behavioral Therapy With Pelvic Floor Muscle Training in Women Receiving Vaginal Reconstructive Surgery for Pelvic Organ Prolapse. Phys Ther. 2023 Sep 1;103(9):pzad059. doi: 10.1093/ptj/pzad059.
PMID: 37318279DERIVEDJakus-Waldman S, Brubaker L, Jelovsek JE, Schaffer JI, Ellington DR, Mazloomdoost D, Whitworth R, Gantz MG; NICHD Pelvic Floor Disorders Network (PFDN). Risk Factors for Surgical Failure and Worsening Pelvic Floor Symptoms Within 5 Years After Vaginal Prolapse Repair. Obstet Gynecol. 2020 Nov;136(5):933-941. doi: 10.1097/AOG.0000000000004092.
PMID: 33030871DERIVEDLukacz ES, Sridhar A, Chermansky CJ, Rahn DD, Harvie HS, Gantz MG, Varner RE, Korbly NB, Mazloomdoost D; Eunice Kennedy Shriver National Institute of Child Health and Human Development Pelvic Floor Disorders Network (PFDN). Sexual Activity and Dyspareunia 1 Year After Surgical Repair of Pelvic Organ Prolapse. Obstet Gynecol. 2020 Sep;136(3):492-500. doi: 10.1097/AOG.0000000000003992.
PMID: 32769645DERIVEDSutkin G, Zyczynski HM, Sridhar A, Jelovsek JE, Rardin CR, Mazloomdoost D, Rahn DD, Nguyen JN, Andy UU, Meyer I, Gantz MG; NICHD Pelvic Floor Disorders Network. Association between adjuvant posterior repair and success of native tissue apical suspension. Am J Obstet Gynecol. 2020 Feb;222(2):161.e1-161.e8. doi: 10.1016/j.ajog.2019.08.024. Epub 2019 Aug 23.
PMID: 31449806DERIVEDLukacz ES, Warren LK, Richter HE, Brubaker L, Barber MD, Norton P, Weidner AC, Nguyen JN, Gantz MG. Quality of Life and Sexual Function 2 Years After Vaginal Surgery for Prolapse. Obstet Gynecol. 2016 Jun;127(6):1071-1079. doi: 10.1097/AOG.0000000000001442.
PMID: 27159758DERIVEDBarber MD, Brubaker L, Burgio KL, Richter HE, Nygaard I, Weidner AC, Menefee SA, Lukacz ES, Norton P, Schaffer J, Nguyen JN, Borello-France D, Goode PS, Jakus-Waldman S, Spino C, Warren LK, Gantz MG, Meikle SF; Eunice Kennedy Shriver National Institute of Child Health and Human Development Pelvic Floor Disorders Network. Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial. JAMA. 2014 Mar 12;311(10):1023-34. doi: 10.1001/jama.2014.1719.
PMID: 24618964DERIVEDBarber MD, Kenton K, Janz NK, Hsu Y, Dyer KY, Greer WJ, White A, Meikle S, Ye W. Validation of the activities assessment scale in women undergoing pelvic reconstructive surgery. Female Pelvic Med Reconstr Surg. 2012 Jul-Aug;18(4):205-10. doi: 10.1097/SPV.0b013e31825e6422.
PMID: 22777368DERIVEDBarber MD, Janz N, Kenton K, Hsu Y, Greer WJ, Dyer K, White A, Meikle S, Ye W. Validation of the surgical pain scales in women undergoing pelvic reconstructive surgery. Female Pelvic Med Reconstr Surg. 2012 Jul-Aug;18(4):198-204. doi: 10.1097/SPV.0b013e31825d65aa.
PMID: 22777367DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Marie Gantz
- Organization
- RTI International
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew Barber, MD
The Cleveland Clinic
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 9, 2008
First Posted
January 18, 2008
Study Start
February 1, 2008
Primary Completion
July 1, 2013
Study Completion
July 1, 2013
Last Updated
October 22, 2020
Results First Posted
October 22, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share